Pfizer Inc (NYSE:PFE)
$ 28.01 -0.17 (-0.6%) Market Cap: 158.72 Bil Enterprise Value: 215.50 Bil PE Ratio: 0 PB Ratio: 1.72 GF Score: 77/100

Pfizer Inc at JPMorgan Healthcare Conference Transcript

Jan 14, 2020 / 11:30PM GMT
Release Date Price: $37.96 (+1.67%)
Christopher Thomas Schott
JP Morgan Chase & Co, Research Division - Senior Analyst

Good afternoon. I'm Chris Schott at JPMorgan. It's my pleasure to be hosting a fireside chat today with Pfizer. From the company, we have Albert Bourla, the company's Chairman and CEO.

Before I start, I did want to mention that as in the past, we're going to be hosting this fireside, but we will not be doing a breakout after the presentation.

Questions & Answers

Christopher Thomas Schott
JP Morgan Chase & Co, Research Division - Senior Analyst

So maybe, Albert, just to kick off, you're roughly a year into your tenure as CEO at Pfizer. Maybe discuss that first year in the role, the changes you've made to Pfizer during that time and the priorities you have as you look out to 2020.

Albert Bourla
Pfizer Inc. - Chairman of the Board & CEO

Thank you. Thank you for having me here. We started the year with 3 businesses. And as you said, we very quickly took decisive and thoughtful steps to strengthen each

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot